RxDoctor Payments Data

Gregory Hazen, MD

Ophthalmology · Saginaw, MINPI 1174528863

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.8%), food and beverage and other — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Alcon Research LLC at 49.8% of the total. Reporting peaked in 2022 at $1,652 and has fallen 85.1% since, to $247 in 2025.

$2,812in general payments, 2019–2025

Across 36 payments — averaging $78.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$1K
  • Alcon$698
  • Carl Zeiss Meditec USA, Inc.$503
  • Rxsight Inc$153
  • Bausch & Lomb Americas Inc.$19
  • Beaver-visitec International, Inc.$18
  • plus $22 from 2 others
$30,000in research payments, 2019–2025

Across 6 payments — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$30K

What the payments were for

  • Consulting fees$1,40050%
  • Speaking & faculty fees$261%
  • Food & beverage$1,15641%
  • Gifts$181%
  • Other$2138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,812 in reported general payments places this provider in the 70th percentile of 674 ophthalmology providers in Michigan.

See all ophthalmology providers in Michigan

Medicare billing

Part B allowed, 2024
$311,056
Medicare patients
472
Services billed
2,217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bromfenac Sodium468$91,913
BesivanceBesifloxacin Hcl299$64,495
ProlensaBromfenac Sodium70$23,793
Prednisolone Acetate402$12,041
LumiganBimatoprost23$11,978
MoxifloxacinMoxifloxacin Hcl545$7,879
Timolol Maleate31$7,016
IlevroNepafenac13$4,633
Brimonidine Tartrate47$3,091
Fluorometholone32$2,340
Ketorolac Tromethamine134$2,142
Latanoprost90$1,954
Fml ForteFluorometholone12$1,931
ErythromycinErythromycin Base85$1,172
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat22$649

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →